Study of the Gut Hormone Analogue G3215 in Adult Subjects
Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
A randomised, placebo controlled Phase I study to investigate the safety, tolerability,
pharmacokinetics and pharmacodynamics of G3215 in adult subjects.